seri
novel
alkynyl
pyrimidin
nucleosid
analogu
sugar
moieti
replac
conform
restrict
zand
spacer
phthalimido
pyrimidin
ring
synthes
use
sonogashira
crosscoupl
reaction
cytostat
activ
evalu
novel
compound
show
eisom
exhibit
gener
better
cytostat
activ
correspond
zisom
eisom
exhibit
best
cytostat
effect
evalu
malign
cell
line
particularli
hepatocellular
carcinoma
hep
ic
lm
howev
compound
also
cytotox
human
normal
fibroblast
wi
zisom
show
highli
specif
antiprolif
activ
hep
ic
lm
cytotox
wi
moreov
compound
express
margin
inhibitori
activ
synthesi
cytostat
antihiv
evalu
new
unsatur
acycl
pyrimidin
nucleosid
analogu
mani
nucleosid
analogu
interest
biolog
properti
arisen
substitut
uracil
base
deoxyuridin
seri
pyrimidin
nucleosid
contain
alkynyl
group
shown
possess
signific
antivir
andor
anticanc
properti
nucleosid
longer
alkynyl
chain
posit
express
appreci
antivir
activ
contrast
correspond
alkyl
deriv
show
decreas
antivir
activ
increas
side
chain
length
introduct
rigid
allen
moieti
linker
heterocycl
base
hydroxymethyl
group
led
compound
adenallen
cytallen
effect
inhibit
replic
hiv
furthermor
thymin
spacer
first
acycl
nucleosid
analogu
exhibit
potent
inhibit
thymidin
kinas
catalyz
phosphoryl
certain
antivir
drug
report
pyrimidin
purin
contain
c
z
exhibit
antiprolif
effect
malign
human
tumour
cell
line
alkynyl
substitut
pyrimidin
deriv
l
lascorb
acid
although
slight
inhibitori
potenc
cytomegaloviru
cmv
varicellazost
viru
vzv
uracil
deriv
l
lascorb
acid
show
pronounc
cytostat
activ
cervic
carcinoma
hela
also
report
z
nucleosid
analogu
show
select
activ
result
prompt
us
synthes
seri
novel
z
e
pyrimidin
contain
alkynyl
longer
side
chain
fig
evalu
cytostat
antihiv
potenc
cell
cultur
key
precursor
z
iia
e
nphthalimido
butenyl
iib
crosscoupl
alkyn
synthes
condens
z
ia
e
ib
z
ia
e
ib
deriv
nphthalimid
synthes
use
classic
gabriel
reaction
differ
substitu
posit
pyrimidin
ring
introduc
reaction
deriv
iia
iib
optim
sonogashira
pd
catalyz
reaction
import
note
reaction
perform
room
temperatur
order
avoid
format
bicycl
furopyrimidin
coproduct
produc
heat
reaction
mixtur
reaction
z
e
nphthalimido
butenyl
variou
termin
alkyn
presenc
palladium
catalyst
copper
iodid
cocatalyst
dmf
room
temperatur
gave
zand
euracil
deriv
scheme
h
c
nmr
data
given
tabl
section
full
agreement
propos
structur
fig
signal
h
c
reson
observ
characterist
moieti
constitut
structur
pyrimidin
nucleosid
analogu
proton
exhibit
distinct
chemic
shift
ppm
wherea
proton
along
c
c
doubl
bond
observ
ppm
tabl
chemic
shift
phenyl
proton
ppm
phthalimido
proton
ppm
chemic
shift
found
rang
ppm
proton
rang
ppm
configur
along
doubl
bond
evalu
j
coupl
constant
tabl
valu
coupl
constant
involv
six
spin
system
includ
j
determin
simul
due
small
ddj
ratio
exampl
simul
multiplet
compar
experiment
spectrum
figur
vinyl
j
j
coupl
signal
half
width
hz
smaller
j
coupl
constant
hz
respect
accord
zisom
along
doubl
bond
hand
larger
j
coupl
constant
hz
respect
conform
eisom
eisom
exhibit
larger
chemic
shift
differ
dd
ppm
zisom
dd
ppm
signific
h
c
chemic
shift
differ
eand
zisom
observ
present
figur
perus
figur
show
clear
distinct
sever
h
c
chemic
shift
respect
zand
econfigur
along
doubl
bond
analysi
focus
conform
properti
novel
nucleosid
analogu
j
j
coupl
constant
show
unrestrict
rotat
along
involv
singl
bond
full
agreement
proton
methylen
group
isochron
evalu
noe
enhanc
proton
substitu
show
interact
would
indic
prefer
conform
state
addit
noe
data
indic
close
spatial
proxim
moieti
attach
compound
evalu
cytostat
activ
malign
human
tumour
cell
line
murin
leukemia
human
tlymphocyt
cem
cervic
carcinoma
hela
pancreat
carcinoma
colorect
adenocarcinoma
sw
breast
epitheli
adenocarcinoma
hepatocellular
carcinoma
hep
well
normal
diploid
human
fibroblast
wi
tabl
cytostat
activ
compound
compar
novel
alkynyl
substitut
olefin
pyrimidin
compound
show
better
antiprolif
activ
malign
tumour
cell
structur
relat
unsubstitut
uracil
fluorosubstitut
uracil
deriv
contain
nphthalimido
butenyl
side
chain
seri
zizom
alkynyl
nphthalimido
butenyl
pyrimidin
deriv
compound
contain
hexynyl
octynyl
pbutylphenylethynyl
side
chain
exhibit
moder
cytostat
effect
evalu
cell
line
particularli
hepatocellular
carcinoma
hep
ic
lm
fig
howev
compound
also
cytotox
normal
human
fibroblast
wi
ic
lm
fig
contrari
compound
ppentylphenylethynyl
side
chain
show
select
antiprolif
effect
growth
hepatocellular
carcinoma
hep
ic
lm
howev
compound
lesser
cytostat
activ
hep
cell
line
standard
among
eisom
substitut
alkynyl
nphthalimido
pyrimidin
deriv
compound
contain
ppentylphenylethynyl
side
chain
exhibit
best
antiprolif
effect
evalu
cell
line
ic
rang
lm
normal
fibroblast
ic
lm
besid
compound
hexynyl
heptynyl
phenylbutynyl
side
chain
show
cytostat
activ
particularli
hepatocellular
carcinoma
hep
ic
lm
fig
thu
compound
emerg
interest
lead
compound
cytostat
activ
could
use
structur
optim
biolog
studi
hep
cell
compound
evalu
inhibitori
activ
human
tlymphocyt
cem
cell
tabl
compound
show
specif
albeit
slight
activ
compound
exhibit
moder
activ
none
virus
sensit
inhibitori
activ
test
compound
except
compound
ec
lm
ec
lm
influenza
h
n
compound
coxsacki
viru
ec
lm
vaccinia
viru
ec
lm
compound
varicellazost
viru
ec
lm
howev
ec
valu
compound
close
toxic
threshold
therefor
unclear
whether
observ
activ
due
specif
antivir
effect
indirectli
cytotoxiccytostat
activ
test
compound
novel
z
e
unsatur
acycl
uracil
deriv
prepar
use
sonogashira
coupl
z
e
comparison
cytostat
activ
zand
eisom
alkynyl
olefin
pyrimidin
deriv
infer
eisom
show
better
cytostat
activ
furthermor
introduct
phenyl
ring
longer
side
chain
caus
increas
cytostat
effect
thu
pentylphenylethynyl
substitut
olefin
pyrimidin
deriv
show
pronounc
inhibitori
activ
test
tumour
cell
line
ic
lm
includ
human
normal
fibroblast
contrari
zisom
show
select
inhibitori
activ
hep
cell
line
ic
lm
thu
result
cytostat
examin
indic
compound
suitabl
candid
biolog
studi
lead
drug
structur
optim
figur
doserespons
curv
test
compound
hepatocellular
carcinoma
hep
panel
cell
line
inocul
onto
seri
standard
microtit
plate
day
cellsml
depend
doubl
time
specif
cell
line
test
agent
ad
five
dilut
incub
h
work
dilut
freshli
prepar
day
test
compound
prepar
solut
dmso
solvent
also
test
eventu
inhibitori
activ
adjust
concentr
work
concentr
h
incub
cell
growth
rate
evalu
perform
mtt
assay
sigma
detect
dehydrogenas
activ
viabl
cell
mtt
cell
prolifer
assay
colorimetr
assay
system
measur
reduct
tetrazolium
compon
mtt
insolubl
formazan
product
mitochondria
viabl
cell
purpos
substancetr
medium
discard
mtt
ad
well
concentr
h
incub
precipit
dissolv
dmso
absorb
od
optic
densiti
measur
micropl
reader
nm
absorb
directli
proport
cell
viabil
percentag
growth
pg
cell
line
calcul
accord
one
follow
two
express
mean
od
test
mean
od
tzero
p
pg
od
test
mean
od
tzero
od
ctrl
meanod
tzero
mean
od
test
mean
od
tzero
pg
od
test
mean
od
tzero
tzero
mean
od
tzero
averag
optic
densiti
measur
exposur
cell
test
compound
mean
od
test
averag
optic
densiti
measur
desir
period
time
mean
od
ctrl
averag
optic
densiti
measur
desir
period
time
exposur
cell
test
compound
test
point
perform
quadrupl
three
individu
experi
result
express
ic
concentr
necessari
inhibit
calcul
doserespons
curv
use
linear
regress
analysi
fit
test
concentr
give
pg
valu
respect
refer
valu
antivir
activ
base
examin
virusinduc
cytopath
syncytia
format
cem
cell
cultur
determin
essenti
describ
previous
antivir
activ
test
compound
herp
simplex
viru
type
